Real-World Outcomes of Patients with Relapsed/Refractory Multiple Myeloma Treated with Teclistamab and Talquetamab; A Multicenter Analysis from the Greek Myeloma Study GroupIoannis Ntanasis-Stathopoulos, Eirini Katodrytou,Evdoxia Hatjiharissi,Emmanouil Spanoudakis,Vasiliki Douka,Despina Fotiou,Vasiliki Labropoulou,Dimitra Dalampira,Vasiliki Spiliopoulou,Theodosia Papadopoulou,Dimitrios Christoulas,Panagiotis Malandrakis,Anthi Bouchla,Vasiliki Pappa,Efstathios Kastritis,Evangelos Terpos,Meletios Dimopoulos,Maria GavriatopoulouBLOOD(2024)引用 0|浏览3AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要